Global Drug Facility
The Global Drug Facility has changed the landscape of TB care since its creation in 2001 by increasing access to high quality and affordable TB treatments & diagnostics to population in need. In 2014, we have delivered more than 24 million treatment courses to 133 countries. GDF is today the largest supplier of quality assured patient treatments (first line drugs, second line drugs and paediatric forms) worldwide in the public sector. GDF is a unique TB medicines procurement mechanism providing as well technical assistance and innovative tools to countries, and supporting key projects like TB REACH, Expand TB, TB Expert in the diagnostic field.
GDF Information on Bedaquiline
GDF Information on Delamanid
GDF information on paediatric formulations
In This Section
GDF is ISO 9001:2000 compliant for provision of quality-assured anti-TB drugs and related services to eligible national TB control programmes.